Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-15

FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Naloxone hydrochloride by Hikma Pharmaceuticals USA Inc., approving an updated regulatory action for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)